These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12375660)

  • 1. Clinical specificity and sensitivity of a blood screening assay for detection of HIV-1 and HCV RNA.
    Vargo J; Smith K; Knott C; Wang S; Fang C; McDonough S; Giachetti C; Caglioti S; Gammon R; Gilbert D; Jackson JB; Richards W; Stramer S; Mimms L
    Transfusion; 2002 Jul; 42(7):876-85. PubMed ID: 12375660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical and clinical sensitivity of the Procleix Ultrio HIV-1/HCV/HBV assay in samples with a low viral load.
    Katsoulidou A; Moschidis Z; Sypsa V; Chini M; Papatheodoridis GV; Tassopoulos NC; Mimidis K; Karafoulidou A; Hatzakis A
    Vox Sang; 2007 Jan; 92(1):8-14. PubMed ID: 17181585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Evaluation of procleix HIV/HCV RNA diagnostic assay].
    Song AJ; Zhang CT; Li XH; Li J; Wang YC
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2006 Mar; 20(1):36-8. PubMed ID: 16642216
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity of the Procleix HIV-1/HCV assay for detection of human immunodeficiency virus type 1 and hepatitis C virus RNA in a high-risk population.
    Jackson JB; Smith K; Knott C; Korpela A; Simmons A; Piwowar-Manning E; McDonough S; Mimms L; Vargo JM
    J Clin Microbiol; 2002 Jul; 40(7):2387-91. PubMed ID: 12089252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a new molecular assay for detection of human immunodeficiency virus type 1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA.
    McCormick MK; Dockter J; Linnen JM; Kolk D; Wu Y; Giachetti C
    J Clin Virol; 2006 Jul; 36(3):166-76. PubMed ID: 16427802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Follow-up of six blood donors highlights the complementary role and limitations of hepatitis C virus antibody and nucleic acid amplification tests.
    Hyland C; Seed CR; Kiely P; Parker S; Cowley N; Bolton W
    Vox Sang; 2003 Jul; 85(1):1-8. PubMed ID: 12823724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multicenter performance evaluation of a transcription-mediated amplification assay for screening of human immunodeficiency virus-1 RNA, hepatitis C virus RNA, and hepatitis B virus DNA in blood donations.
    Koppelman MH; Assal A; Chudy M; Torres P; de Villaescusa RG; Reesink HW; Lelie PN; Cuypers HT
    Transfusion; 2005 Aug; 45(8):1258-66. PubMed ID: 16078910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening.
    Jongerius JM; Sjerps M; Cuijpers HT; van Drimmelen HA; van der Poel CL; Reesink HW; Molijn MH; Peeters GA; Peeters TP; Lelie PN
    Transfusion; 2002 Jun; 42(6):792-7. PubMed ID: 12147034
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yield of HCV and HIV-1 NAT after screening of 3.6 million blood donations in central Europe.
    Roth WK; Weber M; Buhr S; Drosten C; Weichert W; Sireis W; Hedges D; Seifried E
    Transfusion; 2002 Jul; 42(7):862-8. PubMed ID: 12375658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus-1 and hepatitis C virus RNA among South African blood donors: estimation of residual transfusion risk and yield of nucleic acid testing.
    Fang CT; Field SP; Busch MP; Heyns Adu P
    Vox Sang; 2003 Jul; 85(1):9-19. PubMed ID: 12823725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of a transcription-mediated amplification-based HCV and HIV-1 RNA duplex assay for screening individual blood donations: a comparison with a minipool testing system.
    Candotti D; Richetin A; Cant B; Temple J; Sims C; Reeves I; Barbara JA; Allain JP
    Transfusion; 2003 Feb; 43(2):215-25. PubMed ID: 12559017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative evaluation of a triplex nucleic acid test for detection of HBV DNA, HCV RNA, and HIV-1 RNA, with the Procleix Tigris System.
    Xiao X; Zhai J; Zeng J; Tian C; Wu H; Yu Y
    J Virol Methods; 2013 Feb; 187(2):357-61. PubMed ID: 23142222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multicenter evaluation of individual donor nucleic acid testing (NAT) for simultaneous detection of human immunodeficiency virus -1 & hepatitis B & C viruses in Indian blood donors.
    Makroo RN; Choudhury N; Jagannathan L; Parihar-Malhotra M; Raina V; Chaudhary RK; Marwaha N; Bhatia NK; Ganguly AK
    Indian J Med Res; 2008 Feb; 127(2):140-7. PubMed ID: 18403791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nucleic acid technology screening of Australian blood donors for hepatitis C and human immunodeficiency virus-1 RNA: comparison of two high-throughput testing strategies.
    Mison L; Seed CR; Margaritis AR; Hyland C;
    Vox Sang; 2003 Jan; 84(1):11-9. PubMed ID: 12542729
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical performance of a new multiplex assay for the detection of HIV-1, HIV-2, HCV, HBV, and HEV in blood donations in Catalonia (Spain).
    Sauleda S; Bes M; Piron M; Ong E; Coco SB; Carrió J; Linnen JM
    Transfusion; 2023 Nov; 63(11):2098-2105. PubMed ID: 37767741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Significant closure of the human immunodeficiency virus type 1 and hepatitis C virus preseroconversion detection windows with a transcription-mediated-amplification-driven assay.
    Kolk DP; Dockter J; Linnen J; Ho-Sing-Loy M; Gillotte-Taylor K; McDonough SH; Mimms L; Giachetti C
    J Clin Microbiol; 2002 May; 40(5):1761-6. PubMed ID: 11980957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity of HCV RNA and HIV RNA blood screening assays.
    Lelie PN; van Drimmelen HA; Cuypers HT; Best SJ; Stramer SL; Hyland C; Allain JP; Moncharmont P; Defer C; Nübling M; Glauser A; da Silva Cardoso M; Viret JF; Lankinen MH; Grillner L; Wirthmüller U; Coste J; Schottstedt V; Masecar B; Dax EM
    Transfusion; 2002 May; 42(5):527-36. PubMed ID: 12084160
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection.
    Busch MP; Glynn SA; Wright DJ; Hirschkorn D; Laycock ME; McAuley J; Tu Y; Giachetti C; Gallarda J; Heitman J; Kleinman SH;
    Transfusion; 2005 Dec; 45(12):1853-63. PubMed ID: 16371038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multi-Chinese blood center study testing serologic-negative donor samples for hepatitis C virus and human immunodeficiency virus with nucleic acid testing.
    Shan H; Ren FR; Zhao HY; Zhang YZ; Wen GX; Yao FZ; Gao GJ; Yan LX; Jiang CF; Bai XH; Tiemuer MH; Tu YQ; Zhu FM; Zheng YR; Cui L; Liu CL; Gong XY; Lv QS; Zheng P; Ziermann R; Ness P; Wang JX
    Transfusion; 2007 Nov; 47(11):2011-6. PubMed ID: 17958529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the analytical and operational performance of two viral nucleic acid test blood screening systems: Procleix Tigris and cobas s 201.
    Assal A; Barlet V; Deschaseaux M; Dupont I; Gallian P; Guitton C; Morel P; David B; De Micco P
    Transfusion; 2009 Feb; 49(2):289-300. PubMed ID: 19000230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.